Population: Children below or equal to 2 years old diagnosed with RSV and admitted to King Chulalongkorn Memorial Hospital. RSV, children, mutation
Conditions
Interventions
Children who received Palivizumab, Nirsevimab, Clesrovimab, or whose mothers were vaccinated with RSVpreF during pregnancy.,Children who received no immunoprophylaxis or are beyond the protection peri
Health Services Research,Health Services Research
Immunized children.,Nonimmunized children.
Sponsors
The Thai Redcross Society
Eligibility
Sex/Gender
All
Age
No minimum to 2 Years
Inclusion criteria
Inclusion criteria: 1 Children must be no more than 2 years old. 2 Must be diagnosed with a respiratory tract infection with laboratory-confirmed RSV via rapid antigen test or PCR. 3 The patient must be admitted for inpatient treatment at the pediatric ward of King Chulalongkorn Memorial Hospital. 4 Guardians or legal representatives must provide written informed consent for data collection and, if applicable, the collection of additional specimens for genetic testing.
Exclusion criteria
Exclusion criteria: 1 Patients who have medical contraindications for respiratory specimen collection. This includes: 1.1 Prior surgery of the sinuses or skull base. 1.2 History of facial or skull base fractures. 1.3 Encephalocele (protrusion of the brain through a skull defect).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical characteristics one time at medically attended visit Interview and review medical records | — |
Secondary
| Measure | Time frame |
|---|---|
| Genotypic analysis one time at medically attended visit Next generation sequencing | — |
Countries
Thailand
Contacts
Public ContactNapaporn Chantasrisawad
King Chulalongkorn Memorial Hospital
Outcome results
None listed